Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (37)
Amit Nautiyal, Sofia Michopoulou & Matt Guy. (2023) Dosimetry in Lu-177-DOTATATE peptide receptor radionuclide therapy: a systematic review. Clinical and Translational Imaging.
Crossref
Crossref
Amit Nautiyal, Ashish K Jha, Sneha Mithun & Venkatesh Rangarajan. (2022) Dosimetry in Lu-177-PSMA-617 prostate-specific membrane antigen targeted radioligand therapy: a systematic review. Nuclear Medicine Communications 43:4, pages 369-377.
Crossref
Crossref
Ulrika Jahn, Ezgi Ilan, Mattias Sandström, Mark Lubberink, Ulrike Garske-Román & Anders Sundin. (2021) Peptide Receptor Radionuclide Therapy (PRRT) with 177Lu-DOTATATE; Differences in Tumor Dosimetry, Vascularity and Lesion Metrics in Pancreatic and Small Intestinal Neuroendocrine Neoplasms. Cancers 13:5, pages 962.
Crossref
Crossref
Nikhil Gupta, Ravi Kankotia, Ara Sahakian, Preeth Jayaram, Alex Shindel, Elizabeth Dong, Paul Korc, Mohamad Eloubeidi & James Buxbaum. (2019) Endoscopic Ultrasound Assessment of Pancreatic Duct Diameter Predicts Neuroendocrine Tumors and Other Pancreas Masses. Pancreas 48:1, pages 66-69.
Crossref
Crossref
Michele Simbolo, Caterina Vicentini, Andrea Mafficini, Matteo Fassan, Serena Pedron, Vincenzo Corbo, Luca Mastracci, Borislav Rusev, Corrado Pedrazzani, Luca Landoni, Federica Grillo, Sara Cingarlini, Guido Rindi, Claudio Luchini, Aldo Scarpa & Rita T. Lawlor. (2018) Mutational and copy number asset of primary sporadic neuroendocrine tumors of the small intestine. Virchows Archiv 473:6, pages 709-717.
Crossref
Crossref
Niraj Naswa & C. S. Bal. 2013. Theranostics, Gallium-68, and Other Radionuclides. Theranostics, Gallium-68, and Other Radionuclides
321
351
.
Kjell Öberg. (2012) Diagnostic work-up of gastroenteropancreatic neuroendocrine tumors. Clinics 67, pages 109-112.
Crossref
Crossref
Richard A. Feelders, Leo J. Hofland, Dik J. Kwekkeboom, StevenW. Lamberts & Wouter W. de Herder. 2012. Handbook of Neuroendocrinology. Handbook of Neuroendocrinology
761
778
.
Anna Tzontcheva. (2010) Neuroendocrine Tumors — Laboratory Diagnosis. Journal of Medical Biochemistry 29:4, pages 254-264.
Crossref
Crossref
Caroline S Verbeke. (2010) Endocrine tumours of the pancreas. Histopathology 56:6, pages 669-682.
Crossref
Crossref
Valeria Giandomenico. (2010) Molecular pathology of gastrointestinal neuroendocrine tumours – selected topics. Diagnostic Histopathology 16:5, pages 243-250.
Crossref
Crossref
Jean-Pierre Droz, Isabelle Ray-Coquard & Jean-Louis PeixV. Hervieu & J.-A. Chayvialle. 2010. Tumeurs malignes rares. Tumeurs malignes rares
217
220
.
Guido Rindi, Silvia Pizzi, Tiziana D’Adda & Cesare Bordi. 2010. Endocrine Pathology:. Endocrine Pathology:
351
365
.
Kjell Öberg. (2009) Genetics and molecular pathology of neuroendocrine gastrointestinal and pancreatic tumors (gastroenteropancreatic neuroendocrine tumors). Current Opinion in Endocrinology, Diabetes and Obesity 16:1, pages 72-78.
Crossref
Crossref
Chamutal Gur, Gadi Lalazar, Asher Salmon, Victoria Dubiner & David J. Gross. (2007) Metastatic pancreatic neuroendocrine tumor presenting as a pituitary space occupying lesion: a case report. Pituitary 11:3, pages 293-297.
Crossref
Crossref
O. BIGE, B. SAATLI, M. SECIL, M. KOYUNCUOGLU & U. SAYGILI. (2008) Small cell neuroendocrine carcinoma of the endometrium and laparoscopic staging: a clinicopathologic study of a case and a brief review of the literature. International Journal of Gynecological Cancer 18:4, pages 838-843.
Crossref
Crossref
C. Lepage & J. Guigay. 2008. Tumeurs endocrines thoraciques et digestives. Tumeurs endocrines thoraciques et digestives
21
26
.
Richard P. Baum, Sergio Sandrucci & Stefan Adams. 2008. Radioguided Surgery. Radioguided Surgery
252
261
.
Jun-Young Park, Tae-Sup Lee, Tae-Hyun Choi, Gi-Jeong Cheon, Chang-Woon Choi & Ok-Doo Awh. (2007) A comparative study of 188Re(V)-meso-DMSA and 188Re(V)-rac-DMSA: preparation and in vivo evaluation in nude mice xenografted with a neuroendocrine tumor. Nuclear Medicine and Biology 34:8, pages 1029-1036.
Crossref
Crossref
Irina A. Lubensky & Zhengping Zhuang. (2007) Molecular Genetic Events in Gastrointestinal and Pancreatic Neuroendocrine Tumors. Endocrine Pathology 18:3, pages 156-162.
Crossref
Crossref
Aurel Perren, Martin Anlauf & Paul Komminoth. (2007) Molecular profiles of gastroenteropancreatic endocrine tumors. Virchows Archiv 451:S1, pages 39-46.
Crossref
Crossref
Tomasz Grzela, Agata Bialoszewska & Robert Brawura-Biskupski-Samaha. (2006) Nuclear medicine in the treatment of neuroendocrine tumours—problems and perspectives. European Journal of Nuclear Medicine and Molecular Imaging 34:4, pages 444-447.
Crossref
Crossref
Eva-Maria Duerr & Daniel C. Chung. (2007) Molecular genetics of neuroendocrine tumors. Best Practice & Research Clinical Endocrinology & Metabolism 21:1, pages 1-14.
Crossref
Crossref
Dimitrios Papadogias, Polyzois Makras, Ioannis Griniatsos, Gregory Kaltsas & Ashley B Grossman. (2006) Advances in the detection and management of neuroendocrine (carcinoid and pancreatic islet cell) tumours. Current Opinion in Endocrinology and Diabetes 13:4, pages 356-361.
Crossref
Crossref
Peter Simon, Elisabeth Spilcke-Liss & Henri Wallaschofski. (2006) Endocrine Tumors of the Pancreas. Endocrinology and Metabolism Clinics of North America 35:2, pages 431-447.
Crossref
Crossref
T. Shah, D. Hochhauser, R. Frow, A. Quaglia, A. P. Dhillon & M. E. Caplin. (2006) Epidermal Growth Factor Receptor Expression and Activation in Neuroendocrine Tumours. Journal of Neuroendocrinology 18:5, pages 355-360.
Crossref
Crossref
Maja Berkoviç, Tamara Čačev, Vanja Zjačiç-Rotkviç & Sanja Kapitanoviç. (2006) TNF-α Promoter Single Nucleotide Polymorphisms in Gastroenteropancreatic Neuroendocrine Tumors. Neuroendocrinology 84:5, pages 346-352.
Crossref
Crossref
Guido Rindi, Anne Couvelard, Jean-Yves Scoazec & Cesare Bordi. (2005) Évaluation de la malignité dans les tumeurs endocrines digestives : recommandations pratiques. Annales de Pathologie 25:6, pages 487-498.
Crossref
Crossref
Guido Rindi & Cesare Bordi. (2005) Aetiology, molecular pathogenesis and genetics. Best Practice & Research Clinical Gastroenterology 19:4, pages 519-534.
Crossref
Crossref
Tahir Shah & Martyn Caplin. (2005) Biotherapy for metastatic endocrine tumours. Best Practice & Research Clinical Gastroenterology 19:4, pages 617-636.
Crossref
Crossref
S Pizzi, C Azzoni, L Bottarelli, N Campanini, T D'Adda, C Pasquali, G Rossi, G Rindi & C Bordi. (2005) RASSF1A promoter methylation and 3p21.3 loss of heterozygosity are features of foregut, but not midgut and hindgut, malignant endocrine tumours. The Journal of Pathology 206:4, pages 409-416.
Crossref
Crossref
Gregory A. Kaltsas, G. Michael Besser & Ashley B. Grossman. (2004) The Diagnosis and Medical Management of Advanced Neuroendocrine Tumors. Endocrine Reviews 25:3, pages 458-511.
Crossref
Crossref
G Rindi, A Ubiali & V Villanacci. (2004) The phenotype of gut endocrine tumours. Digestive and Liver Disease 36, pages S26-S30.
Crossref
Crossref
Silvia Pizzi, Cinzia Azzoni, Daniela Bassi, Lorena Bottarelli, Massimo Milione & Cesare Bordi. (2003) Genetic alterations in poorly differentiated endocrine carcinomas of the gastrointestinal tract. Cancer 98:6, pages 1273-1282.
Crossref
Crossref
Jeffrey A. Norton & Robert T. Jensen. (2003) Current surgical management of Zollinger–Ellison syndrome (ZES) in patients without multiple endocrine neoplasia-type 1 (MEN1). Surgical Oncology 12:2, pages 145-151.
Crossref
Crossref
P. Capelli, G. Martignoni, A. Scarpa, G. Zamboni & A. Pesci. 2003. Imaging of the Pancreas. Imaging of the Pancreas
161
175
.
C. Bordi, T. D'Adda, S. Pizzi, P. Crafa & G. Rindi. (2002) The assessment of malignancy in endocrine tumours of the gastrointestinal tract. Current Diagnostic Pathology 8:6, pages 421-429.
Crossref
Crossref